UseGrants

DoW Bone Marrow Failure, Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACAAmount not specifiedDue Nov 4, 2026
View & apply on Grants.gov →

This Department of War (Defense Health Agency) Bone Marrow Failure Investigator-Initiated Research Award supports translational and clinical research, preclinical model studies, and IND-enabling wo…

Deadline
Nov 4, 2026
Posted
Jun 17, 2026
Award amount
Amount not specified
Focus areas
Science and Technology and other Research and Development

Don’t miss this deadline

We’ll email you before Nov 4, 2026 so you have time to apply.

In plain English

This Department of War (Defense Health Agency) Bone Marrow Failure Investigator-Initiated Research Award supports translational and clinical research, preclinical model studies, and IND-enabling work, but does not support clinical trials. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; a Partnering PI option is available. Preliminary data relevant to the proposed project are required. No award amounts are listed.

AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

About this grant

Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical research including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, this award mechanism does not support clinical trials. IIRA applications may also support Investigational New Drug (IND)-enabling efforts such as lead compound characterization, and assessments of formulation and stability, absorption, distribution, metabolism and excretion, dose/response and toxicology. Distinctive Features: This funding mechanism allows for a partnering Principal Investigator (PI). Only the initiating PI will submit a pre-application, but both PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials.

Let AI draft your application

Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.

Application Kit — $49 one-time

Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.

Get the Application Kit

Related grants

Other open grants funding Science and Technology and other Research and Development — soonest deadline first.

Also listed under Defense Health Agency Contracting Activity - DHACA and Science & Research Grants.

Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.